Newsroom

Corporate announcement: COVID-19 update
23 MAR
Corporate announcement: Update concerning novel coronavirus (COVID-19)
Read more
Neuraxpharm reinforces presence in Poland with the acquisition of Glenmark’s CNS product portfolio
25 FEB
Neuraxpharm acquires Glenmark’s CNS product portfolio in Poland along with its CNS commercial team and Jacek Sawicki is appointed General Manager of Neuraxpharm Polska as of 1^st April.
Read more
Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm
23 JAN
Neuraxpharm launches Neuraxpharm Austria and acquires Easypharm OTC GmbH, an Austrian Consumer Healthcare company.
Read more
Neuraxpharm expands Southern European presence with expansion into Portugal
28 NOV
Javier Mercadé to head up established Southern European region comprising Italy, Spain and now Portugal
Read more
Neuraxpharm enters booming CBD market with the acquisition of leading Switzerland-based S.T.U. GmbH
29 OCT
Neuraxpharm establishes presence in Switzerland with acquisition of leading CBD company, S.T.U. GmbH, owner of market leading brand Hemplix^TM
Read more

123 4 5 7

Corporate announcement: COVID-19 update